• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » NuvoAir inks deal with Roche Italy for cystic fibrosis care

NuvoAir inks deal with Roche Italy for cystic fibrosis care

January 3, 2020 By Sean Whooley

NuvoAir announced that Roche Italy will distribute its digital respiratory technology to certain cystic fibrosis (CF) centers across Italy.

NuvoAir’s respiratory platform is designed to allow patients to assess lung function in their own homes and respond to specific symptom questionnaires. The data collected by the platform helps the patient understand their progress and can be shared with their medical team in real-time, according to the company. Doctors and physiotherapists can use that data to predict the worsening of the disease, enabling them to focus on the most critical cases and improve their workflow.

The partnership aims to reduce the frequency of hospital visits, which in turn could reduce the chance of contracting infections, such as chronic lung infections that are common in cystic fibrosis patients.

“We are honored to partner with Roche,” NuvoAir founder & CEO Lorenzo Consoli said in a news release. “We are working with many CF centers across Europe, but never in partnership with a pharmaceutical company. Roche Italy is showing that it wants to position the customer at the center of its strategy and to think holistically about the customer experience. Thanks to Roche Italy, CF patients in Italy will now be able to benefit from a solution that helps them improve the management of their disease.”

“We are delighted to begin this partnership with NuvoAir,” added Roche Italy’s Elia Ganzi. “NuvoAir has designed an excellent respiratory platform that truly has the potential to deliver concrete medical advancements to CF patients during their disease path and optimize workflow for the medical team. This partnership is very strategic for us, with a view to promoting an open innovation path that makes Roche more and more a supplier of integrated healthcare solutions and not just drugs.”

Filed Under: Business/Financial News, Respiratory Tagged With: NuvoAir, Roche

More recent news

  • Data backs DermaSensor skin cancer detection device
  • GE HealthCare expands digital imaging portfolio with enhanced MIM Encore software
  • Accelus wins FDA clearance for MRI compatibility of FlareHawk spinal implants
  • Presidio wins FDA IDE for ultra-low frequency neuromod, hires new CFO
  • Epiminder study backs implantable EEG tech

About Sean Whooley

Sean Whooley is an associate editor who mainly produces work for MassDevice, Medical Design & Outsourcing and Drug Delivery Business News. He received a bachelor's degree in multiplatform journalism from the University of Maryland, College Park. You can connect with him on LinkedIn or email him at [email protected].

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy